State Representative Christina Hagan (R-Alliance) today testified on House Bill 255 in the House Community and Family Advancement Committee. House Bill 255 seeks to limit the use of abortion-inducing drugs to those labeled expressly for such purpose by the FDA, and is sponsored by Representatives Hagan and Tom Brinkman (R-Cincinnati).

“Ensuring that women's healthcare is top notch should be a priority of this legislature," said Representative Hagan. "There should be no room for compromise when administering drugs out of context that can be and are harmful to a woman's health."

The legislation would ban drugs like methotrexate, a drug used as a chemotherapy agent, from being used to induce abortions. Chemical abortions involving the use of methotrexate have risen considerably in recent years, and both Rep. Hagan and Rep. Brinkman expressed concern at the usage of these other drugs, the effects of which are not always certain.

“This bill is a logical progression from the bill I sponsored in 2004," said Representative Brinkman. "It will help safe guard women and their unborn children from this terrible practice."

The bill is receiving further consideration in the House Community and Family Advancement Committee.

Featured Posts

Rep. Christina Hagan Named Vice Chair Of House Study Committee


Representative Christina M. Hagan (R-Alliance) is pleased to announce that she has been named the vice chair of the House Study Committee on Higher Education Reform.


Rep. Christina Hagan Encourages Constituents To Submit Online Legislative Survey


State Representative Christina Hagan (R-Alliance) has set up an online legislative survey in an effort to gain feedback from the residents of the 50th Ohio House District regarding a variety of state issues. The survey can be accessed at